Kaplan M A, Ferry J A, Harris N L, Jacobson J O
Department of Pathology, Massachusetts General Hospital, Boston 02115.
Am J Clin Pathol. 1994 May;101(5):590-6. doi: 10.1093/ajcp/101.5.590.
The authors analyzed the clonality of 15 samples of B-cell lymphoproliferations arising in eight organ allograft recipients, using immunoglobulin (Ig) gene rearrangement and the fused terminal fragment of episomal Epstein-Barr virus (EBV) DNA as independent clonal markers. The tumors arose from 1 month to 4 years following transplantation. All tumors were monomorphous, high-grade lymphomas of immunoblastic (6 cases), large-cell noncleaved (centroblastic, 1 case), or small noncleaved (1 case) type. All tumors were highly aggressive and failed to respond to decreased immunosuppression alone. Each tumor had clonal Ig gene rearrangements, including those that were negative for surface Ig. In 13 of 15 specimens (seven of the eight cases), the tumors also contained latent, circularized EBV genome. In 10 specimens from six patients, the tumors contained a single predominant form of episomal EBV DNA, indicating clonal cellular proliferation of an EBV-infected progenitor cell. Three specimens from one patient showed more than one band of episomal EBV DNA, suggesting oligoclonal expansion, despite the detection of only a single clone by Ig gene rearrangement. Linear replicating EBV DNA was not detected in any of the cases. Synchronous or metachronous specimens from multiple sites were studied in five patients, four of which were EBV-positive cases. Two patients had identical Ig gene arrangements in each specimen, indicating a single neoplastic clone at all sites; one case was EBV-negative, and the other had identical EBV episomes in each specimen. In the other three cases, apparently different Ig gene rearrangements were found at different sites. In two of these, however, the same predominant EBV episome was present at each site, indicating a common clonal origin. The third case had oligoclonal EBV bands in each specimen, with distinct patterns in at least two different sites, suggesting true multiclonality. Analysis of EBV genomes is a useful adjunct to Ig gene analysis in assessing the clonality of these lesions.
作者使用免疫球蛋白(Ig)基因重排和游离型爱泼斯坦-巴尔病毒(EBV)DNA的融合末端片段作为独立的克隆标志物,分析了8例器官移植受者中出现的15个B细胞淋巴增殖性病变样本的克隆性。这些肿瘤在移植后1个月至4年出现。所有肿瘤均为单形性、高级别淋巴瘤,免疫母细胞型(6例)、大细胞无裂型(中心母细胞型,1例)或小无裂型(1例)。所有肿瘤均具有高度侵袭性,仅降低免疫抑制对此无效。每个肿瘤均有克隆性Ig基因重排,包括那些表面Ig阴性的肿瘤。在15个标本中的13个(8例中的7例)中,肿瘤还含有潜伏的、环化的EBV基因组。在6例患者的10个标本中,肿瘤含有单一优势形式的游离型EBV DNA,表明EBV感染的祖细胞发生了克隆性细胞增殖。1例患者的3个标本显示游离型EBV DNA有不止一条带,提示寡克隆扩增,尽管通过Ig基因重排仅检测到一个克隆。所有病例均未检测到线性复制的EBV DNA。对5例患者的多个部位的同步或异时标本进行了研究,其中4例为EBV阳性病例。2例患者的每个标本均有相同的Ig基因排列,表明所有部位均为单一肿瘤克隆;1例为EBV阴性,另1例的每个标本均有相同的EBV游离体。在其他3例中,不同部位发现了明显不同的Ig基因重排。然而,其中2例在每个部位均存在相同的优势EBV游离体,表明起源于共同的克隆。第3例的每个标本均有寡克隆EBV条带,至少在两个不同部位有不同的模式,提示真正的多克隆性。在评估这些病变的克隆性时,EBV基因组分析是Ig基因分析的有用辅助手段。